FDA.reportPublic FDA data

Omvoh 200 MG per 2 ML Prefilled Syringe

RxCUI
2703048
RxNorm name
Omvoh 200 MG per 2 ML Prefilled Syringe
Display name
Omvoh 200 MG per 2 ML Prefilled Syringe
Full name
Omvoh 200 MG per 2 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761279Omvohmirikizumab-mrkz351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
472cbe04-263e-433d-9a0f-58c1b50b715aOmvoh 200 MG per 2 ML Prefilled SyringeSY18These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104
472cbe04-263e-433d-9a0f-58c1b50b715a2 ML Omvoh 100 MG/ML Prefilled SyringeSY18These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104
472cbe04-263e-433d-9a0f-58c1b50b715aomvoh 200 MG in 2 ML Prefilled SyringePSN18These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104
472cbe04-263e-433d-9a0f-58c1b50b715a2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe [Omvoh]SBD18These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104